Company profile: Q2 Solutions
1.1 - Company Overview
Company description
- Provider of leading global clinical trials laboratory services, partnering with biopharmaceutical, medical device and diagnostics customers to transform science and data into actionable medical insights, spanning Discovery through Clinical Trials to Commercialization. Services include infectious disease testing, biorepository solutions, Labmatrix sample and consent tracking, anatomic pathology, DNA/RNA extraction, and whole human genome sequencing.
Products and services
- Whole Human Genome Sequencing: Illumina NovaSeq‑based sequencing method optimized for FFPE and intact material, enabling whole human genome characterization for clinical research programs
- Biorepository Solutions: Global-scale biorepository management system overseeing the entire lifecycle of specimens, delivering short‑term and long‑term storage across a global network of biorepositories
- Infectious Disease Testing: Drug-development-focused service executing testing for infectious diseases including flu, SARS‑CoV‑2, pneumonia, meningitis, and pathogenic bacteria to support clinical trial programs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Q2 Solutions
Neri Science
HQ: United States
Website
- Description: Provider of customized research and clinical trial solutions to private companies and public-sector organizations, with global reach, experience, long-standing relationships with leading researchers and key institutions around the world, and a proven commitment to state-of-the science research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neri Science company profile →
Brains On-Line
HQ: United States
Website
- Description: Provider of contract research services in the life sciences and pharmaceutical fields, specializing in preclinical testing of central nervous system (CNS)-targeted drugs, and supporting the discovery and development process for any compound.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Brains On-Line company profile →
Amador Bioscience
HQ: United States
Website
- Description: Provider of translational sciences, clinical pharmacology, bioanalysis, biomarker, and clinical research services to biopharmaceutical companies to support drug development. Offerings include immunoassays and cell-based assays for biomarkers and anti-drug antibodies, biometrics and pharmacometrics, regulatory affairs, and support for global clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amador Bioscience company profile →
Impopharma
HQ: Canada
Website
- Description: Provider of comprehensive drug product formulation and process development, along with wide-ranging analytical testing services for the pharmaceutical industry, specializing in nasal and pulmonary drug products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Impopharma company profile →
Oruka Therapeutics
HQ: United States
Website
- Description: Provider of biologic therapies for chronic skin diseases, including monoclonal antibodies: ORKA-001 targeting IL-23p19 for psoriasis and other inflammatory diseases; ORKA-002 targeting IL-17A/F for psoriasis and other inflammatory diseases; and ORKA-003, a discovery-stage program for psoriasis, psoriatic arthritis, and related conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oruka Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Q2 Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Q2 Solutions
2.2 - Growth funds investing in similar companies to Q2 Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Q2 Solutions
4.2 - Public trading comparable groups for Q2 Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →